Back to HRTX

CITADEL ADVISORS LLC → HRTX

CITADEL ADVISORS LLC HRTX Position History

Heron Therapeutics, Inc. • Healthcare

Quarters held
11
Latest value
$4K
Q3 2026
Peak value
$450K
First seen
Q1 2026

Dollar value over time

Show data table
PeriodPosition value
Q1 2026$158K
Q1 2026$28K
Q1 2026$450K
Q1 2026$17K
Q2 2026$11K
Q2 2026$9K
Q2 2026$11K
Q2 2026$9K
Q3 2026$5K
Q3 2026$150K
Q3 2026$4K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$4K12.2K——
Q3 2026$150K477.2K——
Q3 2026$5K16.2K——
Q2 2026$9K21.0K——
Q2 2026$11K26.1K——
Q2 2026$9K21.0K——
Q2 2026$11K26.1K——
Q1 2026$17K21.0K——
Q1 2026$450K562.3K——
Q1 2026$28K34.6K——
Q1 2026$158K196.9K——

Other funds holding HRTX

Other CITADEL ADVISORS LLC positions

ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$13.2B
ETHA

ISHARES TR

$11.2B
SPY

SPDR S&P 500 ETF TR

$3B
MSFT

MICROSOFT CORP

$2.9B
ETHA

ISHARES TR

$2.7B
SPY

SPDR S&P 500 ETF TR

$2.6B
SPY

STATE STR SPDR S&P 500 ETF T

$2.4B